InventisBio (SH:688382) Xin Lang Cai Jing·2025-09-10 02:14Group 1 - Yifang Biotechnology's stock increased by 5.22%, reaching 35.66 CNY per share, with a trading volume of 279 million CNY and a turnover rate of 1.89%, resulting in a total market capitalization of 20.623 billion CNY [1] - Yifang Biotechnology, established on January 11, 2013, and listed on July 25, 2022, is located in the China (Shanghai) Free Trade Zone and focuses on the research, production, and sales of innovative drugs, with 100% of its main business revenue coming from technology licensing and cooperation [1] Group 2 - Guolian Fund has a significant holding in Yifang Biotechnology, with its Guolian Medical Consumption Mixed A Fund (015032) reducing its stake by 71,100 shares in the second quarter, now holding 152,100 shares, which accounts for 5.93% of the fund's net value, making it the third-largest holding [2] - The Guolian Medical Consumption Mixed A Fund has achieved a year-to-date return of 61.78%, ranking 290 out of 8,177 in its category, and a one-year return of 83.58%, ranking 619 out of 7,982 [2]